Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
T LYMPHOCYTE MODIFIED BY DOUBLE CHIMERIC ANTIGEN RECEPTOR AND PREPARATION METHOD THEREOF
Document Type and Number:
WIPO Patent Application WO/2017/031863
Kind Code:
A1
Abstract:
Provided are a T lymphocyte modified by double chimeric antigen receptor and a preparation method thereof. A chimeric antigen receptor (CAR-L) with a low affinity and a chimeric antigen receptor with a high affinity (CAR-H) are constructed, and are used for respectively recognizing two tumor-associated antigens, and respectively contain a CD3ζ sequence and a costimulatory molecule (costimulatory molecule, CM) signal sequence. The CAR-L and the CAR-H are simultaneously transfected into the T lymphocyte, and the modified T lymphocyte can be effectively activated only by simultaneously recognizing the two tumor-associated antigens, thus reinforcing the targeting of the CAR-T lymphocyte in killing tumors and reducing the damage to normal tissues.

Inventors:
JIANG SHU (CN)
JI XILUAN (CN)
ZHANG YUN (CN)
LUO ZHAOXIA (CN)
Application Number:
PCT/CN2015/096861
Publication Date:
March 02, 2017
Filing Date:
December 09, 2015
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHENZHEN WINGOR BIOTECHNOLOGY CO LTD (CN)
International Classes:
C12N5/10; A61K35/17; A61P35/00; C12N15/867
Foreign References:
CN105087495A2015-11-25
CN103483452A2014-01-01
CN104853766A2015-08-19
Other References:
DATABASE nucleotide [O] 17 February 2001 (2001-02-17), PAUL, S. ET AL.: "Synthetic construct SP-8C5 recombinant single chain Fv antibody mRNA, partial cds", XP055174530, retrieved from ncbi Database accession no. AF329458
DATABASE nucleotide [O] 30 August 2014 (2014-08-30), CAO, X. ET AL.: "Synthetic construct anti-HER2 single chain antibody variable region gene, partial cds", XP055366615, retrieved from ncbi Database accession no. KM016462
Attorney, Agent or Firm:
SHENZHEN KINDWALF INTELLECTUAL PROPERTY FIRM (CN)
Download PDF: